# CPT 96401

> Medicare paid $77.86 for CPT 96401 in the office (non-facility) setting and $77.86 in a facility under the Q3 2022 Physician Fee Schedule, effective July 2022. These are the national allowed amounts before the ~2% sequestration cut and before locality (GPCI) adjustment. This price has been unchanged since Q1 2022, when it decreased 5.5%.

## What it is

Administration of a cancer-fighting drug as a single injection into the fatty tissue just under the skin or into a muscle, rather than through a drip into a vein. Although the injection itself takes moments, the service reflects the surrounding work: verifying the order and dose, handling a hazardous drug safely, assessing the patient before and after, and watching for immediate reactions. This entry is for non-hormonal anti-cancer agents; hormone-type anti-cancer injections and intravenous chemotherapy routes are recorded under separate codes.

## Selected release

- Release: Q3 2022 (2022 C)
- Effective: July 1 – September 30, 2022
- Status indicator: A
- Office (non-facility) national allowed amount: $77.86
- Facility national allowed amount: $77.86
- Sequestration: not applied

## RVUs and formula

- Work RVU: 0.21
- Office (non-facility) practice expense RVU: 1.99
- Facility practice expense RVU: 1.99
- Malpractice RVU: 0.05
- Conversion factor: 34.6062
- Formula: `(work_rvu × work_gpci + pe_rvu × pe_gpci + mp_rvu × mp_gpci) × conversion_factor`

## Source and citation

- Source: Physician relative value file (Q3 2022)
- CMS file: https://www.cms.gov/files/zip/rvu22c-updated-06172022.zip
- Parsed file: PPRRVU22_JUL.csv, row 17,325
- Canonical page: https://localishealth.com/cpt/96401/2022/A
- Release-specific citation URL: https://localishealth.com/cpt/96401/2022/C
- Last significant update: 2026-08-04T03:11:49+00:00